Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 13Urinary Bladder Neoplasms 12Kidney Neoplasms 7Carcinoma, Renal Cell 6Urethral Neoplasms 2Carcinoma, Transitional Cell 2Wilms Tumor 1Urologic Neoplasms 1Urogenital Neoplasms 1Testicular Neoplasms 1Seminoma 1Prostate Adenocarcinoma 1Penile Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Muscle Invasive Bladder Cancer 1Graft vs Host Disease 1Genomic Instability 1

Interventions

Gemcitabine 24Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2pegfilgrastim 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urethral Neoplasms × Neoadjuvant Therapy × Genitourinary × Clear all
NCT00055835 2013-01-31

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

SWOG Cancer Research Network

Phase 2 Completed
7 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00080795 2012-10-22

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

M.D. Anderson Cancer Center

Phase 2 Completed
65 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡